This Article Full Text Full Text (PDF) All Versions of this Article: 113/9/1196    most recent CIRCULATIONAHA.105.602094v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Nahrendorf, M. Articles by Ertl, G. Search for Related Content PubMed PubMed Citation Articles by Nahrendorf, M. Articles by Ertl, G. Related Collections Cardio-renal physiology/pathophysiology Remodeling Cardiovascular imaging agents/Techniques CT and MRI Animal models of human disease Heart failure - basic studies Imaging Related Article

(Circulation. 2006;113:1196-1202.)
© 2006 American Heart Association, Inc.

Heart Failure

Factor XIII Deficiency Causes Cardiac Rupture, Impairs Wound Healing, and Aggravates Cardiac Remodeling in Mice With Myocardial Infarction

Matthias Nahrendorf, MD; Kai Hu, MD; Stefan Frantz, MD; Farouc A. Jaffer, MD, PhD; Ching-Hsuan Tung, PhD; Karl-Heinz Hiller, PhD; Sabine Voll; Peter Nordbeck, MD; David Sosnovik, MD; Stefan Gattenlöhner, MD; Mikhail Novikov, MD; Gerhard Dickneite, PhD; Guy L. Reed, MD; Peter Jakob, PhD; Anthony Rosenzweig, MD; Wolfgang R. Bauer, MD, PhD; Ralph Weissleder, MD, PhD; Georg Ertl, MD

From the Medizinische Klinik und Poliklinik I, Universität Würzburg, Würzburg, Germany (M. Nahrendorf, K.H., S.F., P.N., S.G., W.R.B., G.E.); Center for Molecular Imaging Research, Massachusetts General Hospital, Harvard Medical School, Charlestown, Mass (M.N., F.A.J., C.T., D.S., R.W.); Physikalisches Institut (EP5), Universität Würzburg, Würzburg, Germany (K.H., S.V., P.J.); Cardiovascular Research Center, Massachusetts General Hospital, Harvard Medical School, Charlestown, Mass (M. Novikov, A.R.); ZLB Behring, Marburg, Germany (G.D.); and Cardiology Division, Department of Medicine, Medical College of Georgia, Augusta (G.L.R.).

Correspondence to Dr Georg Ertl, Medizinische Universitätsklinik, Universität Würzburg, Josef Schneider-Strasse 2, 97080 Würzburg, Germany. E-mail Ertl_G{at}medizin.uni-wuerzburg.de

Received May 27, 2005; de novo received November 16, 2005; revision received December 16, 2005; accepted December 23, 2005.

Background— Identification of key molecular players in myocardial healing could lead to improved therapies, reduction of scar formation, and heart failure after myocardial infarction (MI). We hypothesized that clotting factor XIII (FXIII), a transglutaminase involved in wound healing, may play an important role in MI given prior clinical and mouse model data.

Methods and Results— To determine whether a truly causative relationship existed between FXIII activity and myocardial healing, we prospectively studied myocardial repair in FXIII-deficient mice. All FXIII^–/– and FXIII^–/+ (FXIII activity <5% and 70%) mice died within 5 days after MI from left ventricular rupture. In contradistinction, FXIII^–/– mice that received 5 days of intravenous FXIII replacement therapy had normal survival rates; however, cardiac MRI demonstrated worse left ventricular remodeling in these reconstituted FXIII^–/– mice. Using a FXIII-sensitive molecular imaging agent, we found significantly greater FXIII activity in wild-type mice and FXIII^–/– mice receiving supplemental FXIII than in FXIII^–/– mice (P<0.05). In FXIII^–/– but not in reconstituted FXIII^–/– mice, histology revealed diminished neutrophil migration into the MI. Reverse transcriptase–polymerase chain reaction studies suggested that the impaired inflammatory response in FXIII^–/– mice was independent of intercellular adhesion molecule and lipopolysaccharide-induced CXC chemokine, both important for cell migration. After MI, expression of matrix metalloproteinase-9 was 650% higher and collagen-1 was 53% lower in FXIII^–/– mice, establishing an imbalance in extracellular matrix turnover and providing a possible mechanism for the observed cardiac rupture in the FXIII^–/– mice.

Conclusions— These data suggest that FXIII has an important role in murine myocardial healing after infarction.

---

 

CLINICAL PERSPECTIVE

Related Article:

Issue Highlights
Circulation 2006 113: 1155. [Full Text]

This article has been cited by other articles:

				D. Fraccarollo, P. Galuppo, S. Schraut, S. Kneitz, N. van Rooijen, G. Ertl, and J. Bauersachs Immediate Mineralocorticoid Receptor Blockade Improves Myocardial Infarct Healing by Modulation of the Inflammatory Response Hypertension, April 1, 2008; 51(4): 905 - 914. [Abstract] [Full Text] [PDF]

				M. Shimazaki, K. Nakamura, I. Kii, T. Kashima, N. Amizuka, M. Li, M. Saito, K. Fukuda, T. Nishiyama, S. Kitajima, et al. Periostin is essential for cardiac healingafter acute myocardial infarction J. Exp. Med., February 18, 2008; 205(2): 295 - 303. [Abstract] [Full Text] [PDF]

				D. Vanhoutte and S. Heymans Factor XIII: the cement of the heart after myocardial infarction? Eur. Heart J., February 2, 2008; 29(4): 427 - 428. [Full Text] [PDF]

				M. Nahrendorf, E. Aikawa, J.-L. Figueiredo, L. Stangenberg, S. W. van den Borne, W. M. Blankesteijn, D. E. Sosnovik, F. A. Jaffer, C.-H. Tung, and R. Weissleder Transglutaminase activity in acute infarcts predicts healing outcome and left ventricular remodelling: implications for FXIII therapy and antithrombin use in myocardial infarction Eur. Heart J., February 2, 2008; 29(4): 445 - 454. [Abstract] [Full Text] [PDF]

				K. Urayama, C. Guilini, N. Messaddeq, K. Hu, M. Steenman, H. Kurose, G. Ert, and C. G. Nebigil The prokineticin receptor-1 (GPR73) promotes cardiomyocyte survival and angiogenesis FASEB J, September 1, 2007; 21(11): 2980 - 2993. [Abstract] [Full Text] [PDF]

				Y. Nakano, H. F. Al-Jallad, A. Mousa, and M. T. Kaartinen Expression and Localization of Plasma Transglutaminase Factor XIIIA in Bone J. Histochem. Cytochem., July 1, 2007; 55(7): 675 - 685. [Abstract] [Full Text] [PDF]

				M. Nahrendorf, C. Badea, L. W. Hedlund, J.-L. Figueiredo, D. E. Sosnovik, G. A. Johnson, and R. Weissleder High-resolution imaging of murine myocardial infarction with delayed-enhancement cine micro-CT Am J Physiol Heart Circ Physiol, June 1, 2007; 292(6): H3172 - H3178. [Abstract] [Full Text] [PDF]

				M. Nahrendorf, D. E. Sosnovik, P. Waterman, F. K. Swirski, A. N. Pande, E. Aikawa, J.-L. Figueiredo, M. J. Pittet, and R. Weissleder Dual Channel Optical Tomographic Imaging of Leukocyte Recruitment and Protease Activity in the Healing Myocardial Infarct Circ. Res., April 27, 2007; 100(8): 1218 - 1225. [Abstract] [Full Text] [PDF]

				D. E. Sosnovik, M. Nahrendorf, N. Deliolanis, M. Novikov, E. Aikawa, L. Josephson, A. Rosenzweig, R. Weissleder, and V. Ntziachristos Fluorescence Tomography and Magnetic Resonance Imaging of Myocardial Macrophage Infiltration in Infarcted Myocardium In Vivo Circulation, March 20, 2007; 115(11): 1384 - 1391. [Abstract] [Full Text] [PDF]

				S. Frantz, K. Hu, B. Bayer, S. Gerondakis, J. Strotmann, A. Adamek, G. Ertl, and J. Bauersachs Absence of NF-{kappa}B subunit p50 improves heart failure after myocardial infarction FASEB J, September 1, 2006; 20(11): 1918 - 1920. [Abstract] [Full Text] [PDF]